Results 11 to 20 of about 631,320 (249)

Case Report: Familial Pseudohyperkalemia Due to Red Blood Cell Membrane Leak in a Chinese Patient

open access: yesFrontiers in Medicine, 2022
Hyperkalemia is a critical condition requiring careful evaluation and timely intervention. Many conditions could manifest as pseudohyperkalemia and it's important to differentiate them as inappropriate potassium-lowering therapy might lead to detrimental
Weijue Xiong   +6 more
doaj   +1 more source

Identification of monocyte-associated genes as predictive biomarkers of heart failure after acute myocardial infarction

open access: yesBMC Medical Genomics, 2021
Background Acute myocardial infarction (AMI) is a major contributor of heart failure (HF). Peripheral blood mononuclear cells (PBMCs), mainly monocytes, are the essential initiators of AMI-induced HF.
Qixin Chen   +5 more
doaj   +1 more source

PRKAR1A and SDCBP Serve as Potential Predictors of Heart Failure Following Acute Myocardial Infarction

open access: yesFrontiers in Immunology, 2022
Background and ObjectivesEarly diagnosis of patients with acute myocardial infarction (AMI) who are at a high risk of heart failure (HF) progression remains controversial.
Qixin Chen   +6 more
doaj   +1 more source

Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Early reports from the COVID‐19 pandemic identified coronary thrombosis leading to ST‐segment–elevation myocardial infarction (STEMI) as a complication of COVID‐19 infection.
Ankeet S. Bhatt   +11 more
doaj   +1 more source

External validation of the GRACE risk score in patients with myocardial infarction in Hungary

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2023
Background: Literature confirms that the Global Registry of Acute Coronary Events (GRACE) risk score provides a better risk evaluation than clinical judgment in patients with acute myocardial infarction.
Tamás Ferenci   +3 more
doaj   +1 more source

Incidence and predictors of left ventricular function change following ST-segment elevation myocardial infarction

open access: yesFrontiers in Cardiovascular Medicine, 2023
AimThe purpose of the study was to assess the incidence and predictors of left ventricular function change in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI.Methods312 patients with STEMI who received primary ...
Chuanfen Liu   +14 more
doaj   +1 more source

Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundIMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) showed that adding the nonstatin ezetimibe to statin therapy further reduced cardiovascular events in patients after an acute coronary syndrome. In a prespecified
Eri Toda Kato   +9 more
doaj   +1 more source

Red blood cell eNOS is cardioprotective in acute myocardial infarction

open access: yesRedox Biology, 2022
Red blood cells (RBCs) were shown to transport and release nitric oxide (NO) bioactivity and carry an endothelial NO synthase (eNOS). However, the pathophysiological significance of RBC eNOS for cardioprotection in vivo is unknown.
Miriam M. Cortese-Krott   +17 more
doaj   +1 more source

Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study

open access: yesFrontiers in Pharmacology, 2022
Introduction: Polypharmacy are commonly observed among older adults with cardiovascular disease. However, multiple medications lead to increased risk of drug-drug interactions (DDIs).
Mei Zhao   +7 more
doaj   +1 more source

Variables associated with pulmonary hypertension screened by echocardiography in chronic myeloid leukemia patients on dasatinib therapy

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundPulmonary hypertension (PH) is a rare but life-threatening adverse event (AE) of dasatinib, but the associated variables are not clear. This study aimed to explore the variables associated with PH by echocardiography in patients with chronic ...
Wenying Jin   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy